Navigation Links
ZyStor seeks to raise $15M for clinical trials

Wauwatosa, Wis. - Looking to raise more venture capital for clinical trials, ZyStor Therapeutics will be one of 30 firms presenting at the annual InvestMidwest venture capital forum next month in Overland Park, Kan.

ZyStor, which also presented at the 2006 forum, would like to raise an additional $1......

Full article >>> State of Wisconsin Investment Board, Hexagon Investments, Apjohn Ventures, and Stonehenge Capital.

ZyStor moved to Milwaukee from St. Louis as a condition for the funding. It had moved to St. Louis from Cambridge, Mass.

Rarified space
......

Full article >>> r has made, especially given the fact that developing a pharmaceutical product is a high-risk proposition.

"The company certainly has made wonderful progress," Neis said. "We're excited about how they are advancing down the development path."

Typically, the existing syndicate of investors will participate in subsequent rounds, and the beneficiary will attempt to lure additional ......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 03/07/07


Related biology technology :

1. ZyStor to exhibit cell disorder treatments
2. Milwaukee area biotech ZyStor seeks more funding
3. ZyStor receives first funding and buys theraputics for rare diseases
4. MATC seeks to turn around falling tech enrollment among women
5. Doyle seeks $30M for e-medical record adoption
6. Third Wave seeks approval of Cystic Fibrosis test
7. Morgridge Institute for Research seeks first CEO
8. Medical College team seeks stem cell patent
9. Big pharma seeks Wisconsin biotech partnerships
10. Doyle seeks $2.5M for biomedical alliance
11. Digital Government Summit seeks to bridge the digital divide
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/7/2016)... ... December 07, 2016 , ... Kara Dwyer Dodge grew up hearing stories of the sea ... in Scituate, Mass., found a sea turtle entangled in the lines of one of his ... a minor sensation because no one could remember ever seeing one so large so close ...
(Date:12/6/2016)... ... 06, 2016 , ... The Osteoarthritis Research Society International (OARSI) ... (FDA) to consider OA as a serious disease. As an organization of professionals ... of OA patients, many of whom may experience progressive disability and decreased quality ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... today announced it has acquired the assets of Theorem Clinical Research - ... focuses on clinical trial drug packaging, labeling, storage, reconciliation, and distribution for ...
(Date:12/6/2016)... PARK, Calif. , Dec. 6, 2016 /PRNewswire/ ... up to $150 million from the National Institutes ... Diseases and the Division of AIDS (NIAID-DAIDS) to ... and other non-vaccine pre-exposure (PreP) agents. Under the ... of preclinical product development services for candidate HIV-prevention ...
Breaking Biology Technology:
(Date:11/21/2016)... , Nov. 21, 2016   Neurotechnology , ... recognition technologies, today announced that the MegaMatcher On ... was submitted for the NIST Minutiae Interoperability ... all the mandatory steps of the evaluation protocol. ... a continuing test of fingerprint templates used to ...
(Date:11/15/2016)... Md. , Nov. 15, 2016  Synthetic ... company developing therapeutics focused on the gut microbiome, ... offering of 25,000,000 shares of its common stock ... common stock at a price to the public ... proceeds to Synthetic Biologics from the offering, excluding ...
(Date:6/22/2016)... 22, 2016  The American College of Medical Genetics and ... Magazine as one of the fastest-growing trade shows during ... the Bellagio in Las Vegas . ... of growth in each of the following categories: net square ... number of attendees. The 2015 ACMG Annual Meeting was ranked ...
Breaking Biology News(10 mins):